DIGESTIVE ENZYMES 50 MG
PAPAIN : 50 MG CELLULASE : 2 UNIT PROTEASE : 6500 UNIT LACTASE : 100 UNIT AMYLASE : 2000 UNIT LIPASE : 145 UNIT BROMELAIN (PINEAPPLE ENZYME) : 50 MG BETAINE HYDROCHLORIDE : 3 MG · DIN 02236927 · MORTER HEALTHSYSTEM
Health Canada status: APPROVED
What is DIGESTIVE ENZYMES?
DIGESTIVE ENZYMES 50 MG contains PAPAIN : 50 MG CELLULASE : 2 UNIT PROTEASE : 6500 UNIT LACTASE : 100 UNIT AMYLASE : 2000 UNIT LIPASE : 145 UNIT BROMELAIN (PINEAPPLE ENZYME) : 50 MG BETAINE HYDROCHLORIDE : 3 MG. It is listed in the Health Canada Drug Product Database under DIN 02236927, held by MORTER HEALTHSYSTEM, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 11-May-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02236927 |
|---|---|
| Brand name | DIGESTIVE ENZYMES |
| Generic / active ingredient | PAPAIN : 50 MG CELLULASE : 2 UNIT PROTEASE : 6500 UNIT LACTASE : 100 UNIT AMYLASE : 2000 UNIT LIPASE : 145 UNIT BROMELAIN (PINEAPPLE ENZYME) : 50 MG BETAINE HYDROCHLORIDE : 3 MG |
| Manufacturer | MORTER HEALTHSYSTEM |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A09AC02 MULTIENZYMES AND ACID PREPARATIONS |
| AHFS class | 28:16.04.12 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 11-May-2018 |
| Original market date | 1998-06-02 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A09AC02 MULTIENZYMES AND ACID PREPARATIONS. 0 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALKA-PAN TABLETS | 35 MG | TABLET | MORTER HEALTHSYSTEM | APPROVED | DIN 02231774 |
| BROMELAIN-PAPAIN | 50 MG | TABLET | SEROYAL INTERNATIONAL INC. | CANCELLED POST MARKET | DIN 00565504 |
| DIGESTIVE ENZYME - TAB | 300 MG | TABLET | ALBI NATURALS | CANCELLED POST MARKET | DIN 02200260 |
| DYGEST | 125 MG | TABLET | CREATIVE NUTRITION CANADA CORP. | CANCELLED POST MARKET | DIN 00665975 |
| ENZYME TABLETS | 65 MG | TABLET | GENERAL NUTRITION CANADA INC. | CANCELLED POST MARKET | DIN 02181312 |
| PRO GEST TAB | 64.8 MG | TABLET | PURE LIFE INTERNATIONAL PRODS INC. | CANCELLED POST MARKET | DIN 01946803 |
| PRO ZYME TAB | 50 MG | TABLET | SPORTSCIENCE LABS INC. | CANCELLED POST MARKET | DIN 00518921 |
| ZYPANAX | 9 MG | TABLET | THERAPEUTIC FOODS CO. | CANCELLED POST MARKET | DIN 00191353 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.